Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Antihypertensive Drugs: Action of Calcium Channel Blockers

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bullous Amyloidosis with Lesional Nikolsky's Sign Positivity.

Indian journal of dermatology·2026

Same author

The relationship between sperm secretion and the Hippo signaling pathway in the rat seminiferous tubules.

Scientific reports·2025

Same author

Alterations in the Hippo Signaling Pathway During Adenogenesis Impairment in Postnatal Mouse Uterus.

Reproductive sciences (Thousand Oaks, Calif.)·2025

Same author

Differences of microbial growth and biofilm formation among periprosthetic joint infection-causing species: an animal study.

International microbiology : the official journal of the Spanish Society for Microbiology·2025

Same author

Vesicular HMGB1 release from neurons stressed with spreading depolarization enables confined inflammatory signaling to astrocytes.

Journal of neuroinflammation·2023

Same author

The effects of coenzyme Q10 and curcumin supplementation in freezing medium for human sperm cryopreservation.

European journal of obstetrics, gynecology, and reproductive biology·2023

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

New addition to the statin's effect.

Sibel Serin-Kilicoglu¹, Sibel Serin Kiliçcoglu, Esra Erdemli

¹Histology-Embriology Department, Rýdvan Ege Hospital, Ufuk University Faculty of Medicine, Ankara, Turkey. sibelserin2005@yahoo.com

The Journal of Trauma

|July 12, 2007

Summary

Simvastatin significantly accelerates bone fracture healing by promoting osteoprogenitor cell formation and vascularization. This study demonstrates simvastatin

Related Experiment Videos

Last Updated: Jul 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

Biomedical Science
Pharmacology
Orthopedics

Background:

Statins, known for cholesterol reduction, may also decrease osteoporotic fracture risk.
Previous observations in humans and animal models suggest a potential link between statin use and reduced fracture incidence.

Purpose of the Study:

To investigate the in vivo effects of simvastatin on the process of bone fracture healing.

Main Methods:

Fifty-four rats with induced closed distal leg fractures were divided into control and two simvastatin dose groups (1 mg/d, 2 mg/d).
Simvastatin was administered subcutaneously near the fracture site daily for five days.
Tibias were histologically examined on days 7, 14, and 21 post-fracture.

Main Results:

Simvastatin treatment significantly accelerated fracture healing stages compared to the control group (p = 0.001).
Increased osteoid formation was observed in simvastatin-treated rats.
No significant dose-dependent variations in healing were noted between the two simvastatin doses.

Conclusions:

Simvastatin demonstrates a significant positive impact on bone fracture healing.
Treatment with simvastatin enhanced the proliferation and differentiation of osteoprogenitor cells.
Accelerated neovascularization and calcification contributed to faster fracture repair in the simvastatin group.